Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Verona Pharma PLC
Cash Equivalents Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Cash Equivalents
$336m
CAGR 3-Years
26%
CAGR 5-Years
52%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Cash Equivalents
ÂŁ3B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Cash Equivalents
$6.9B
CAGR 3-Years
-24%
CAGR 5-Years
5%
CAGR 10-Years
3%
Indivior PLC
LSE:INDV
Cash Equivalents
$302m
CAGR 3-Years
-33%
CAGR 5-Years
-21%
CAGR 10-Years
39%
Hikma Pharmaceuticals PLC
LSE:HIK
Cash Equivalents
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Verona Pharma PLC's Cash Equivalents?
Cash Equivalents
336m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Cash Equivalents amounts to 336m USD.

What is Verona Pharma PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
52%

Over the last year, the Cash Equivalents growth was 31%. The average annual Cash Equivalents growth rates for Verona Pharma PLC have been 26% over the past three years , 52% over the past five years .

Back to Top